# CRISPR Therapeutics AG (CRSP) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from CRISPR Therapeutics AG's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CRSP/mda/fy2025/): filed 2026-02-12; accession 0001193125-26-048957 (https://www.sec.gov/Archives/edgar/data/1674416/000119312526048957/crsp-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CRSP/mda/fy2024/): filed 2025-02-11; accession 0000950170-25-017899 (https://www.sec.gov/Archives/edgar/data/1674416/000095017025017899/crsp-20241231.htm)
- [FY 2023 MD&A](/company/CRSP/mda/fy2023/): filed 2024-02-21; accession 0000950170-24-017571 (https://www.sec.gov/Archives/edgar/data/1674416/000095017024017571/crsp-20231231.htm)
- [FY 2022 MD&A](/company/CRSP/mda/fy2022/): filed 2023-02-21; accession 0000950170-23-003441 (https://www.sec.gov/Archives/edgar/data/1674416/000095017023003441/crsp-20221231.htm)
- [FY 2021 MD&A](/company/CRSP/mda/fy2021/): filed 2022-02-15; accession 0000950170-22-001282 (https://www.sec.gov/Archives/edgar/data/1674416/000095017022001282/crsp-20211231.htm)

Back to /company/CRSP/